Ellen C. Keeley, MD; Cindy L. Grines, MD
Potential Financial Conflicts of Interest:Consultancies: C.L. Grines (Aventis, Guidant, Pfizer, Innercool Therapies, The Medicines Company); Grants received: C.L. Grines (Berlex, GlaxoSmithKline, Pfizer, Guidant, Eli Lilly and Company, SCIMED, Johnson & Johnson, Aventis, Amersham Health, Otsuka, Esperion Therapeutics, Innercool Therapies).
Requests for Single Reprints: Ellen C. Keeley, MD, Division of Cardiology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-8837; e-mail, email@example.com.
Current Author Addresses: Dr. Keeley: Division of Cardiology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-8837.
Dr. Grines: William Beaumont Hospital, 3601 West Thirteen Mile Road, Royal Oak, MI 48073-6769.
Keeley EC, Grines CL. Primary Percutaneous Coronary Intervention for Every Patient with ST-Segment Elevation Myocardial Infarction: What Stands in the Way?. Ann Intern Med. 2004;141:298–304. doi: 10.7326/0003-4819-141-4-200408170-00010
Download citation file:
Published: Ann Intern Med. 2004;141(4):298-304.
Acute Coronary Syndromes, Cardiology, Coronary Heart Disease, Emergency Medicine, Percutaneous Coronary Intervention.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use